Dr. Dilip V. Subhedar, MD

Dr. Subhedar practices at Bon Secours Charity Health System Medical Group in Warwick, New York.

Dr. Subhedar's NPI, 1780699348, was assigned on July 30, 2006. Dr. Subhedar holds New York license 183858-1.

Dr. Subhedar's primary practice is Bon Secours Charity Health System Medical Group, at 20 Grand St, Warwick, NY 10990 in Orange County. The practice phone is (845) 987-3906.

Dr. Subhedar's primary practice is Bon Secours Charity Health System Medical Group in Warwick, New York. Dr. Subhedar is also affiliated with Good Samaritan Hospital. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Subhedar to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subhedar practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Subhedar's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dmand AI has Dr. Subhedar's licenses on file in 2 states: New York and New Jersey.

CMS data shows 710 Medicare services from Dr. Subhedar across 18 procedure codes in 2024, for 292 Medicare patients. Medicare paid $63,502 for them.

CMS counts 292 Medicare patients who saw Dr. Subhedar in 2024. The largest group is 75 to 84, with 111 patients. 75% of them have arthritis, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subhedar's median patient age at 71, with 56% women.

In 2024, Dr. Subhedar wrote 1,719 Medicare Part D claims for 164 patients. 90% of them were for generic drugs. CMS names the drug for 1,556 of them, across 33 drugs with 11 or more claims each, at $73,597 in total drug cost. In 2023, CMS named 1,703 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Subhedar for performance year 2024, reported through an alternative payment model (APM). Dr. Subhedar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Subhedar as offering telehealth.

CMS Open Payments shows 266 general payments to Dr. Subhedar from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $2,168.